Norwegian Rituximab Chronic Fatigue Syndrome (ME/CFS) Trial Fails
The outcome of a positive Rituximab trial for ME/CFS – possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research funding – would have been spectacular but Dr. Mella reported this week in Norway that the trial...
Fuel Shortage: Norwegian Study Expands on Energy Problem in Chronic Fatigue Syndrome (ME/CFS)
Fluge and Mella seem to be working at almost lightning speed. Besides managing their huge Rituximab study (and all the sub- studies within it) and the cyclophosphamide trial, they’re also carrying out large research studies. For years, of course, some...
Hypometabolism Shows Up Again in Chronic Fatigue Syndrome (ME/CFS) Plus Ritxumab Update
Fluge and Mella are best known for their Rituximab work, but just last week Mella reported that they’d found a hypometabolic state in ME/CFS as well. Check out that along with what’s going on with Rituximab, and another chemotherapy/autoimmune drug that...
Breakthough! Norway Wakes Up – Funds Big Multicenter Chronic Fatigue Syndrome Rituximab Trial
The Norwegian Research Council funds the large multi-center Rituximab trial that will determine how effective Rituximab is in chronic fatigue syndrome.Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
